Background: Aspiration community-acquired pneumonia (ACAP) and community-acquired pneumonia (CAP) in patients with aspiration risk factors (AspRFs) are infections associated with anaerobes, but limited evidence suggests their pathogenic role. Research question: What are the aspiration risk factors, microbiology patterns, and empiric anti-anaerobic use in patients hospitalized with CAP? Study design and methods: This is a secondary analysis of GLIMP, an international, multicenter, point-prevalence study of adults hospitalized with CAP. Patients were stratified into three groups: 1) ACAP, 2) CAP/AspRF+ (CAP with AspRF) and 3) CAP/AspRF- (CAP without AspRF). Data on demographics, comorbidities, microbiological results, and anti-anaerobic antibiotics were analyzed in all groups. Patients were further stratified in severe and non-severe CAP groups. Results: We enrolled 2,606 patients with CAP, of which 193 (7.4%) had ACAP. Risk factors independently associated with ACAP were male, bedridden, underweight, a nursing home resident, and having a history of stroke, dementia, mental illness, and enteral tube feeding. Among non-ACAP patients, 1,709 (70.8%) had CAP/AspRF+ and 704 (29.2%) had CAP/AspRF-. Microbiology patterns including anaerobes were similar between CAP/AspRF-, CAP/AspRF+ and ACAP (0.0% vs. 1.03% vs. 1.64%). Patients with severe ACAP had higher rates of total Gram-negative bacteria (64.3% vs. 44.3% vs. 33.3%, p=0.021) and lower rates of total Gram-positive bacteria (7.1% vs. 38.1% vs. 50.0%, p<0.001) when compared to patients with severe CAP/AspRF+ and severe CAP/AspRF-, respectively. The majority of the patients (>50% in all groups) independent of AspRFs or ACAP received specific or broad-spectrum anti-anaerobic coverage antibiotics. Interpretation: Hospitalized patients with ACAP or CAP/AspRF+ had similar anaerobic flora compared to patients without aspiration risk factors. Gram-negative bacteria were more prevalent in patients with severe ACAP. Despite having similar microbiological flora between groups, a large proportion of CAP patients received anti-anaerobic antibiotic coverage.

Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia / J. Marin-Corral, S. Pascual-Guardia, A. Francesco, S. Aliberti, J.R. Masclans, N. Soni, A. Rodriguez, O. Sibila, F. Sanz, G. Sotgiu, A. Anzueto, K. Dimakou, R. Petrino, E. van de Garde, M.I. Restrepo. - In: CHEST. - ISSN 0012-3692. - 159:1(2021), pp. 58-72. [10.1016/j.chest.2020.06.079]

Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia

S. Aliberti
Conceptualization
;
2021

Abstract

Background: Aspiration community-acquired pneumonia (ACAP) and community-acquired pneumonia (CAP) in patients with aspiration risk factors (AspRFs) are infections associated with anaerobes, but limited evidence suggests their pathogenic role. Research question: What are the aspiration risk factors, microbiology patterns, and empiric anti-anaerobic use in patients hospitalized with CAP? Study design and methods: This is a secondary analysis of GLIMP, an international, multicenter, point-prevalence study of adults hospitalized with CAP. Patients were stratified into three groups: 1) ACAP, 2) CAP/AspRF+ (CAP with AspRF) and 3) CAP/AspRF- (CAP without AspRF). Data on demographics, comorbidities, microbiological results, and anti-anaerobic antibiotics were analyzed in all groups. Patients were further stratified in severe and non-severe CAP groups. Results: We enrolled 2,606 patients with CAP, of which 193 (7.4%) had ACAP. Risk factors independently associated with ACAP were male, bedridden, underweight, a nursing home resident, and having a history of stroke, dementia, mental illness, and enteral tube feeding. Among non-ACAP patients, 1,709 (70.8%) had CAP/AspRF+ and 704 (29.2%) had CAP/AspRF-. Microbiology patterns including anaerobes were similar between CAP/AspRF-, CAP/AspRF+ and ACAP (0.0% vs. 1.03% vs. 1.64%). Patients with severe ACAP had higher rates of total Gram-negative bacteria (64.3% vs. 44.3% vs. 33.3%, p=0.021) and lower rates of total Gram-positive bacteria (7.1% vs. 38.1% vs. 50.0%, p<0.001) when compared to patients with severe CAP/AspRF+ and severe CAP/AspRF-, respectively. The majority of the patients (>50% in all groups) independent of AspRFs or ACAP received specific or broad-spectrum anti-anaerobic coverage antibiotics. Interpretation: Hospitalized patients with ACAP or CAP/AspRF+ had similar anaerobic flora compared to patients without aspiration risk factors. Gram-negative bacteria were more prevalent in patients with severe ACAP. Despite having similar microbiological flora between groups, a large proportion of CAP patients received anti-anaerobic antibiotic coverage.
English
Settore MED/10 - Malattie dell'Apparato Respiratorio
Articolo
Esperti anonimi
Ricerca applicata
Pubblicazione scientifica
2021
17-lug-2020
American College of Chest Physicians : Elsevier
159
1
58
72
15
Pubblicato
Periodico con rilevanza internazionale
pubmed
crossref
Aderisco
info:eu-repo/semantics/article
Aspiration risk factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia / J. Marin-Corral, S. Pascual-Guardia, A. Francesco, S. Aliberti, J.R. Masclans, N. Soni, A. Rodriguez, O. Sibila, F. Sanz, G. Sotgiu, A. Anzueto, K. Dimakou, R. Petrino, E. van de Garde, M.I. Restrepo. - In: CHEST. - ISSN 0012-3692. - 159:1(2021), pp. 58-72. [10.1016/j.chest.2020.06.079]
open
Prodotti della ricerca::01 - Articolo su periodico
15
262
Article (author)
Periodico con Impact Factor
J. Marin-Corral, S. Pascual-Guardia, A. Francesco, S. Aliberti, J.R. Masclans, N. Soni, A. Rodriguez, O. Sibila, F. Sanz, G. Sotgiu, A. Anzueto, K. Dimakou, R. Petrino, E. van de Garde, M.I. Restrepo
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S001236922031905X-main.pdf

Open Access dal 18/07/2021

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.78 MB
Formato Adobe PDF
1.78 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/753756
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 21
  • ???jsp.display-item.citation.isi??? 17
social impact